JP2009256253A - Microsphere for cosmetic and cosmetic containing the same - Google Patents
Microsphere for cosmetic and cosmetic containing the same Download PDFInfo
- Publication number
- JP2009256253A JP2009256253A JP2008108256A JP2008108256A JP2009256253A JP 2009256253 A JP2009256253 A JP 2009256253A JP 2008108256 A JP2008108256 A JP 2008108256A JP 2008108256 A JP2008108256 A JP 2008108256A JP 2009256253 A JP2009256253 A JP 2009256253A
- Authority
- JP
- Japan
- Prior art keywords
- cosmetic
- extract
- cleansing
- vesicle
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 68
- 239000004005 microsphere Substances 0.000 title claims abstract description 10
- 239000000284 extract Substances 0.000 claims abstract description 30
- 229940106189 ceramide Drugs 0.000 claims abstract description 15
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims abstract description 14
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims abstract description 14
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims abstract description 14
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims abstract description 14
- BGLMEUKLOVSPCD-ZDCRTTOTSA-N C(CCCCCCCCCCC)(=O)N[C@@H](CCC(O)=O)C(=O)N([C@@H](CCCCN)C(=O)O)C([C@@H](NC(CCCCCCCCCCC)=O)CCC(O)=O)=O Chemical compound C(CCCCCCCCCCC)(=O)N[C@@H](CCC(O)=O)C(=O)N([C@@H](CCCCN)C(=O)O)C([C@@H](NC(CCCCCCCCCCC)=O)CCC(O)=O)=O BGLMEUKLOVSPCD-ZDCRTTOTSA-N 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- 229930182558 Sterol Natural products 0.000 claims abstract description 8
- 235000003702 sterols Nutrition 0.000 claims abstract description 8
- 150000003432 sterols Chemical class 0.000 claims abstract description 8
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 6
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 6
- LNLLNTMHVMIMOG-YUMQZZPRSA-N Gamma-glutamyl-Lysine Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CC[C@H](N)C(O)=O LNLLNTMHVMIMOG-YUMQZZPRSA-N 0.000 claims abstract description 3
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 8
- 239000000232 Lipid Bilayer Substances 0.000 claims description 7
- 239000011538 cleaning material Substances 0.000 claims description 6
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 claims description 5
- 240000000073 Achillea millefolium Species 0.000 claims description 5
- 235000007754 Achillea millefolium Nutrition 0.000 claims description 5
- 229940096998 ursolic acid Drugs 0.000 claims description 5
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 claims description 5
- 241000546188 Hypericum Species 0.000 claims description 4
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 4
- 239000003599 detergent Substances 0.000 claims description 4
- 150000002339 glycosphingolipids Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 abstract description 10
- 238000005299 abrasion Methods 0.000 abstract description 3
- 241001672694 Citrus reticulata Species 0.000 abstract description 2
- 239000012528 membrane Substances 0.000 abstract description 2
- 241001663978 Achillea sibirica Species 0.000 abstract 1
- 241000218203 Coptis japonica Species 0.000 abstract 1
- 241000782597 Hypericum erectum Species 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 150000003675 ursolic acids Chemical class 0.000 abstract 1
- -1 ascorbic acid phosphate ester Chemical class 0.000 description 31
- 239000006185 dispersion Substances 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 12
- 239000004615 ingredient Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 238000004140 cleaning Methods 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 229920001296 polysiloxane Polymers 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 239000006096 absorbing agent Substances 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000002502 liposome Substances 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 238000006748 scratching Methods 0.000 description 3
- 230000002393 scratching effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- FUFAPKOCRZYSHH-CVTBAMPXSA-N benzyl (1s,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a-carboxylate Chemical compound O=C([C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)OCC1=CC=CC=C1 FUFAPKOCRZYSHH-CVTBAMPXSA-N 0.000 description 2
- 229940048864 ceramide 1 Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000006163 transport media Substances 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- PSBDWGZCVUAZQS-UHFFFAOYSA-N (dimethylsulfonio)acetate Chemical compound C[S+](C)CC([O-])=O PSBDWGZCVUAZQS-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- ICFRVXBXPFMEST-UHFFFAOYSA-N 2-butyl-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(CCCC)C(=O)C1=CC=CC=C1 ICFRVXBXPFMEST-UHFFFAOYSA-N 0.000 description 1
- NCLNAHJFXIKYBY-UHFFFAOYSA-N 2-hexyldecyl 16-methylheptadecanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C NCLNAHJFXIKYBY-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- HEVGGTGPGPKZHF-UHFFFAOYSA-N Epilaurene Natural products CC1C(=C)CCC1(C)C1=CC=C(C)C=C1 HEVGGTGPGPKZHF-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 description 1
- QJQCKZOTDIXREF-GUPFHMATSA-N N[C@@H](CCCCN)C(=O)O.C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)O)C(=O)O.C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)O)C(=O)O Chemical compound N[C@@H](CCCCN)C(=O)O.C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)O)C(=O)O.C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)O)C(=O)O QJQCKZOTDIXREF-GUPFHMATSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000010426 asphalt Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229940073609 bismuth oxychloride Drugs 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- JBTHDAVBDKKSRW-UHFFFAOYSA-N chembl1552233 Chemical compound CC1=CC(C)=CC=C1N=NC1=C(O)C=CC2=CC=CC=C12 JBTHDAVBDKKSRW-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- VPWFPZBFBFHIIL-UHFFFAOYSA-L disodium 4-[(4-methyl-2-sulfophenyl)diazenyl]-3-oxidonaphthalene-2-carboxylate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC(C)=CC=C1N=NC1=C(O)C(C([O-])=O)=CC2=CC=CC=C12 VPWFPZBFBFHIIL-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- NQGIJDNPUZEBRU-UHFFFAOYSA-N dodecanoyl chloride Chemical compound CCCCCCCCCCCC(Cl)=O NQGIJDNPUZEBRU-UHFFFAOYSA-N 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- TUKWPCXMNZAXLO-UHFFFAOYSA-N ethyl 2-nonylsulfanyl-4-oxo-1h-pyrimidine-6-carboxylate Chemical compound CCCCCCCCCSC1=NC(=O)C=C(C(=O)OCC)N1 TUKWPCXMNZAXLO-UHFFFAOYSA-N 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- TXGJTWACJNYNOJ-UHFFFAOYSA-N hexane-2,4-diol Chemical compound CCC(O)CC(C)O TXGJTWACJNYNOJ-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- BWOROQSFKKODDR-UHFFFAOYSA-N oxobismuth;hydrochloride Chemical compound Cl.[Bi]=O BWOROQSFKKODDR-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- ZQTHOIGMSJMBLM-BUJSFMDZSA-N pangamic acid Chemical compound CN(C)CC(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZQTHOIGMSJMBLM-BUJSFMDZSA-N 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940117986 sulfobetaine Drugs 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- PDSVZUAJOIQXRK-UHFFFAOYSA-N trimethyl(octadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)C PDSVZUAJOIQXRK-UHFFFAOYSA-N 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、化粧料用に有用な小球体及びそれを含有する化粧料に関する。 The present invention relates to a microsphere useful for cosmetics and a cosmetic containing the same.
クレンジング化粧料や水性洗浄料は、化粧料の有している界面活性能力を利用し、皮膚に付着している汚れを分散媒体中へ分散せしめ、皮膚より離脱せしめる機能を有する。前記分散媒体は、クレンジング化粧料であれば、クレンジング化粧料が含有する油相であり、水性洗浄料では、温水などの洗浄に用いる液体となっている。かかる化粧料は何れも化粧料組成物自体の界面活性能力が高いために、有効成分などを含有させた場合には、化粧料中に保持され皮膚への配向が阻害される場合が少なくなかった。又、この様な皮膚への配向性を高めるためには、リポソームなどの輸送媒体等が利用されるが(例えば、特許文献1を参照)、リポソームなどを利用しても、化粧料成分により崩壊し、目的とした効果が得られない場合も少なからず存した。その一方で、クレンジングや洗浄は、媒体中へ汚れを分散せしめるために、擦過等の物理的処置を伴うので、この様な物理的な処置による輸送媒体の崩壊もネガチブな要因となっている。即ち、クレンジングや洗浄料などの処方構成、使用態様の元でも有効成分を確実に皮膚へ配向させる手段の開発が望まれていた。 Cleansing cosmetics and aqueous detergents have the function of dispersing the dirt adhering to the skin in the dispersion medium and using the surface active ability of the cosmetics. If the dispersion medium is a cleansing cosmetic, it is an oil phase contained in the cleansing cosmetic, and the aqueous cleaning liquid is a liquid used for cleaning such as warm water. Since all of these cosmetics have a high surface-active ability of the cosmetic composition itself, when an active ingredient is included, the cosmetic composition is often retained in the cosmetic and the orientation to the skin is often inhibited. . Moreover, in order to improve such orientation to the skin, a transport medium such as a liposome is used (see, for example, Patent Document 1). However, there were not a few cases where the intended effect could not be obtained. On the other hand, cleansing and cleaning involve physical treatment such as rubbing in order to disperse dirt in the medium, so that the collapse of the transport medium due to such physical treatment is also a negative factor. That is, it has been desired to develop a means for reliably orienting the active ingredient to the skin even under the prescription constitution and usage mode such as cleansing and cleaning materials.
ビス(N−ラウロイルグルタミル)リジンは保湿剤或いは界面活性剤として浴用剤や洗浄料に含有させる技術が知られている(例えば、特許文献2を参照)が、ベシクルを形成させる特性が存することも、かかる成分が含有されるベシクルがクレンジングの製剤成分や洗浄料の製剤成分中でも安定であり、且つ、擦過などの化粧動作にも安定でありながら、皮膚内への有効成分の輸送性に優れることは全く知られていなかった。 Bis (N-lauroylglutamyl) lysine has been known to contain bathing agents and detergents as a moisturizing agent or surfactant (see, for example, Patent Document 2), but there is also a property of forming vesicles. In addition, the vesicles containing such components are stable among cleansing and cleansing formulation components, and are stable in cosmetic operations such as scratching, while being excellent in the transportability of active ingredients into the skin. Was not known at all.
一方、セラミドやフィトステロールをリン脂質とともにリポソームの作成に用いることは既に知られているが(例えば、特許文献3、特許文献4を参照)、ビス(N−ラウロイルグルタミル)リジンとともにベシクルに加工する技術は全く知られていないし、かかる成分が含有されるベシクルがクレンジングの製剤成分や洗浄料の製剤成分中でも安定であり、且つ、擦過などの化粧動作にも安定でありながら、皮膚内への有効成分の輸送性に優れることは全く知られていなかった。 On the other hand, it is already known that ceramide or phytosterol is used together with phospholipids for the preparation of liposomes (see, for example, Patent Document 3 and Patent Document 4), but a technique for processing into vesicles together with bis (N-lauroylglutamyl) lysine. Is not known at all, and the vesicles containing such ingredients are stable among cleansing and cleansing ingredients, and are also effective for cosmetic action such as abrasion, but are active ingredients in the skin. It was not known at all that it was excellent in transportability.
本発明は、この様な状況下為されたものであり、クレンジングの製剤成分や洗浄料の製剤成分中でも安定であり、且つ、擦過などの化粧動作にも安定である、有効成分の皮膚内への輸送手段を提供することを課題とする。 The present invention has been made under such circumstances, and it is stable among cleansing preparation ingredients and cleaning preparation ingredients, and is also effective for cosmetic operations such as abrasion, and into the skin. It is an object to provide a means of transportation.
この様な状況に鑑みて、本発明者らは、クレンジングの製剤成分や洗浄料の製剤成分中でも安定であり、且つ、擦過などの化粧動作にも安定である、有効成分の皮膚内への輸送手段を求めて、鋭意研究努力を重ねた結果、界面活性の高い化粧料に配合すべき小球体であって、ビス(N−ラウロイルグルタミル)リジンと、セラミド及び/又はステロールとを含有する脂質二重膜構造の外殻を有するベシクルがその様な特性を有する輸送担体であることを見出し、発明を完成させるに至った。即ち、本発明は、以下に示す通りである。
<1>界面活性の高い化粧料に配合すべき小球体であって、ビス(N−ラウロイルグルタミル)リジンと、セラミド及び/又はステロールとを含有する脂質二重膜構造の外殻を有するベシクルであることを特徴とする化粧料用小球体。
<2>前記ステロールは、コレステロール及び/又はフィトステロールである、<1>に記載の化粧料用小球体。
<3>ε,γ−グルタミルリジン、オウレン抽出物、ノコギリソウ抽出物、オトギリソウ抽出物、チョウジ抽出物、ウルソール酸類、ポンカン抽出物及びスフィンゴ糖脂質からなる群から選択される有効成分を含有することを特徴とする、<1>又は<2>に記載の化粧料用小球体。
<4>前記界面活性の高い化粧料は、クレンジング化粧料又は水性洗浄料であることを特徴とする、<1>〜<3>何れか1項に記載の化粧料用小球体。
<5><1>〜<4>何れか1項に記載の化粧料用小球体を含有してなる化粧料。
<6>前記化粧料は、クレンジング化粧料又は水性洗浄料であることを特徴とする、<5>に記載の化粧料。
In view of such a situation, the present inventors have transported an active ingredient into the skin that is stable among cleansing and cleaning ingredients, and is also stable in cosmetic operations such as scratching. As a result of intensive research efforts to find a means, it is a small sphere to be blended in cosmetics with high surface activity, and it contains bis (N-lauroylglutamyl) lysine and ceramide and / or sterol. The inventors have found that a vesicle having an outer shell having a multilayer structure is a transport carrier having such characteristics, and has completed the invention. That is, the present invention is as follows.
<1> A vesicle having a lipid bilayer structure outer shell containing bis (N-lauroylglutamyl) lysine and ceramide and / or sterol, which is a spherule to be incorporated into a cosmetic having high surface activity. A cosmetic sphere characterized by being.
<2> The cosmetic spherule according to <1>, wherein the sterol is cholesterol and / or phytosterol.
<3> containing an active ingredient selected from the group consisting of ε, γ-glutamyllysine, auren extract, yarrow extract, hypericum extract, clove extract, ursolic acid, poncan extract and glycosphingolipid. The cosmetic microsphere according to <1> or <2>, which is characterized.
<4> The cosmetic microsphere according to any one of <1> to <3>, wherein the cosmetic having high surface activity is a cleansing cosmetic or an aqueous detergent.
<5> A cosmetic comprising the cosmetic microsphere according to any one of <1> to <4>.
<6> The cosmetic according to <5>, wherein the cosmetic is a cleansing cosmetic or an aqueous cleaning material.
本発明によれば、クレンジングの製剤成分や洗浄料の製剤成分中でも安定であり、且つ、擦過などの化粧動作にも安定である、有効成分の皮膚内への輸送手段を提供することができる。 According to the present invention, it is possible to provide a means for transporting an active ingredient into the skin, which is stable among cleansing preparation ingredients and cleaning preparation ingredients, and is also stable in cosmetic operations such as scratching.
(1)本発明のベシクル
本発明のベシクルは、化粧料用の小球体であって、界面活性の高い化粧料に配合すべき小球体であって、ビス(N−ラウロイルグルタミル)リジンと、セラミド及び/又はステロールとを含有する脂質二重膜構造の外殻を有することを特徴とする。
(1) Vesicles of the present invention The vesicles of the present invention are small spheres for cosmetics, which are to be blended in cosmetics having high surface activity, and are bis (N-lauroylglutamyl) lysine and ceramide And / or having a lipid bilayer outer shell containing sterol.
ビス(N−ラウロイルグルタミル)リジンは、グルタミン酸にラウロイルクロリドを反応させ、N−ラウロイルグルタミン酸となし、このものとリジンとをDCCの様なペプチド合成試薬を用いて縮合することにより得ることが出来る。又、かかる成分については、既に化粧料用の原料として市販されているものが存し、かかる市販品を利用することが出来る。好ましい市販品としては、例えば、旭化成ケミカルズから販売されている「ペリセア(登録商標)L−30」(ビス(N−ラウロイルグルタミル)リジン)等が存する。かかる成分は、ベシクル中に1〜20質量%含有することが好ましく、2〜10質量%含有することがより好ましい。この範囲を外れるとベシクルを形成しない場合が存する。 Bis (N-lauroylglutamyl) lysine can be obtained by reacting glutamic acid with lauroyl chloride, forming N-lauroylglutamic acid, and condensing this with lysine using a peptide synthesis reagent such as DCC. Moreover, about this component, the thing already marketed as a raw material for cosmetics exists, and this commercial item can be utilized. As a preferable commercially available product, for example, “Perisea (registered trademark) L-30” (bis (N-lauroylglutamyl) lysine) sold by Asahi Kasei Chemicals and the like exist. Such component is preferably contained in the vesicle in an amount of 1 to 20% by mass, and more preferably 2 to 10% by mass. There are cases where vesicles are not formed outside this range.
セラミドとしては、セラミド・タイプ1〜セラミド・タイプ7の何れもが使用可能であるが、セラミド・タイプ2乃至はセラミド・タイプ3が市販されており、かかる市販品を利用することが好ましい。セラミド・タイプ2の市販品としては、「セラミドTIC−001」(高砂香料工業株式会社製)、セラミド・タイプ3としては「セラミドIII」(コスモファーム社製)等が好ましく例示できる。その他のタイプのセラミドの市販品としては、例えば、コスモファーム社製の「Ceramide 1」(セラミド 1)、「Ceramide IIIB」(セラミド 3)、「Ceramide VI」(セラミド 6)等が好ましく例示できる。かかる成分は、ベシクル中に0.1〜10質量%含有されることが好ましく、0.5〜5質量%であることがより好ましい。又、かかる成分の含有量は、ビス(N−ラウロイルグルタミル)リジンと同量乃至は1/5質量倍であることが好ましい。この範囲を外れるとベシクルを形成しない場合が存する。 As the ceramide, any of ceramide type 1 to ceramide type 7 can be used, but ceramide type 2 to ceramide type 3 are commercially available, and it is preferable to use such commercially available products. As a commercially available product of ceramide type 2, “ceramide TIC-001” (manufactured by Takasago Inc.), and as ceramide type 3, “ceramide III” (manufactured by Cosmo Farm) can be preferably exemplified. Preferred examples of other types of commercially available ceramides include “Ceramide 1” (Ceramide 1), “Ceramide IIIB” (Ceramide 3), “Ceramide VI” (Ceramide 6) manufactured by Cosmo Farm. This component is preferably contained in the vesicle in an amount of 0.1 to 10% by mass, and more preferably 0.5 to 5% by mass. Further, the content of such a component is preferably the same as that of bis (N-lauroylglutamyl) lysine or 1/5 times the mass. There are cases where vesicles are not formed outside this range.
フィトステロールとしては、一般的にフィトステロール(植物性ステロール)に分類されるものであれば、使用でき、構成成分として、カンペステロール、シトステロール、スティグマスタノール等を含有するものが好ましく例示できる。かかる成分は、穀物の胚芽などを有機溶剤で抽出し、水溶性部分を除去することにより得ることが出来るが、既に市販されているものを購入して利用することが出来る。この様な市販品としては、例えば、「フィトステロールS」(生化学工業株式会社製)等が好ましく例示できる。かかる成分は、ベシクル中に0.1〜10質量%含有されることが好ましく、0.5〜5質量%であることがより好ましい。又、かかる成分の含有量は、ビス(N−ラウロイルグルタミル)リジンと同量乃至は1/5質量倍であることが好ましい。フィトステロールとセラミドの質量比は、1:2〜2:1が好ましい。この範囲を外れるとベシクルを形成しない場合が存する。 Any phytosterol can be used as long as it is generally classified into phytosterols (plant sterols), and those containing campesterol, sitosterol, stigmasteranol and the like can be preferably exemplified. Such components can be obtained by extracting germs of grains and the like with an organic solvent and removing the water-soluble part. However, commercially available products can be purchased. Preferred examples of such commercially available products include “Phytosterol S” (manufactured by Seikagaku Corporation). This component is preferably contained in the vesicle in an amount of 0.1 to 10% by mass, and more preferably 0.5 to 5% by mass. Further, the content of such a component is preferably the same as that of bis (N-lauroylglutamyl) lysine or 1/5 times the mass. The mass ratio of phytosterol and ceramide is preferably 1: 2 to 2: 1. There are cases where vesicles are not formed outside this range.
これらの成分、内包する成分、例えば、次に示す有効成分、セイヨウノコギリソウ等のノコギリソウ抽出物、オトギリソウ抽出物、オウゴン抽出物、オウレン抽出物、ジュ抽出物、クジン抽出物、チョウジ抽出物、ポンカン抽出物、ミカン抽出物などの生薬抽出物、、好ましくは、オウレン抽出物、ノコギリソウ抽出物、オトギリソウ抽出物、チョウジ抽出物及びポンカン抽出物から選択されるもの、アスコルビン酸、アスコルビン酸リン酸エステル、アスコルビン酸グルコシドのようなアスコルビン酸配糖体、4−アルキルレゾルシノール、アルブチン、トラネキサム酸乃至はそのメチルアミドのような誘導体、或いはこれらの塩に代表される美白剤、、ウルソール酸、ウルソール酸ベンジル、ウルソール酸オレイルなどのウルソール酸エステル、好ましくは、ウルソール酸ベンジル、スフィンゴリン脂質、スフィンゴ糖脂質、スフィンゴシンなどのスフィンゴ類、好ましくはスフィンゴ糖脂質、或いは、有効成分以外の成分として、水や1,3−ブタンジオール、1,2−ペンタンジオール、グリセリンなどの多価アルコールなど内水相を構成する成分、高級アルコールや非イオン界面活性剤などの隔壁特性を調整する成分などを常法に従って処理することにより、本発明のベシクルは調整することが出来る。具体的な処理方法としては、粗乳化した後、エクストルーダーやマイクロフルイダイザーなどを用いて整粒し、調整することが好ましく例示できる。斯くして得られたベシクルのクレンジング乃至は洗浄料における好ましい含有量は、化粧料全量に対し、0.005〜10質量%が好ましく、より好ましくは、0.05〜5質量%である。 These components, encapsulated components, for example, the following active ingredients, yarrow extract such as Achillea millefolium, hypericum extract, longon extract, lauren extract, juju extract, clove extract, clove extract, ponkan extract , Extracts of herbal medicines such as mandarin orange extract, preferably, selected from auren extract, yarrow extract, hypericum extract, clove extract and ponkan extract, ascorbic acid, ascorbic acid phosphate ester, ascorbine Ascorbic acid glycosides such as acid glucoside, 4-alkylresorcinol, arbutin, tranexamic acid or derivatives thereof such as methylamide, or whitening agents represented by these salts, ursolic acid, benzyl ursolate, ursolic acid Ursolic acid such as oleyl Tel, preferably sphingos such as benzyl ursolate, sphingophospholipids, glycosphingolipids, sphingosine, preferably glycosphingolipids, or components other than active ingredients such as water, 1,3-butanediol, 1,2 -The vesicle of the present invention can be obtained by treating a component constituting an inner aqueous phase such as a polyhydric alcohol such as pentanediol and glycerin, a component for adjusting partition wall properties such as a higher alcohol and a nonionic surfactant, etc. according to a conventional method. Can be adjusted. As a specific treatment method, preferably, after coarse emulsification, the particle size is adjusted and adjusted using an extruder, a microfluidizer, or the like. The preferable content of the vesicles thus obtained in the cleansing or cleaning material is preferably 0.005 to 10% by mass, more preferably 0.05 to 5% by mass, based on the total amount of the cosmetic.
(2)本発明の化粧料
本発明の化粧料は、前記ベシクルを含有することを特徴とする。この様な形態を採用することにより、ベシクル内に内包した有効成分を皮膚中へと効果的に配向させ、その有効性を高めることが出来る。又、本発明のベシクルを利用することにより、リン脂質を利用したリポソーム等の輸送小球体と異なり、化粧料の製剤成分により、輸送小球体が崩壊する蓋然性が極めて低く、この為、溶剤効果の高い油剤を含有するクレンジング料や、界面活性が極めて高い洗浄料に適用することが出来る。この類い希な点で、クレンジング料や水性洗浄料が好ましい実施形態となる。
(2) Cosmetics of this invention The cosmetics of this invention contain the said vesicle, It is characterized by the above-mentioned. By adopting such a form, it is possible to effectively orient the active ingredient encapsulated in the vesicle into the skin and enhance its effectiveness. Further, by using the vesicles of the present invention, unlike transport globules such as liposomes using phospholipids, the probability of the transport spherules collapsing is extremely low due to the formulation components of cosmetics. It can be applied to cleansing materials containing high oil agents and cleaning materials with extremely high surface activity. In this rare point, cleansing materials and aqueous cleaning materials are preferred embodiments.
本発明の化粧料に於いては、前記成分以外に、化粧料に於いて通常用いられる成分を任意に含有させることが出来る。この様な成分としては、例えば、マカデミアナッツ油、アボガド油、トウモロコシ油、オリーブ油、ナタネ油、ゴマ油、ヒマシ油、サフラワー油、綿実油、ホホバ油、ヤシ油、パーム油、液状ラノリン、硬化ヤシ油、硬化油、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、カルナウバロウ、イボタロウ、ラノリン、還元ラノリン、硬質ラノリン、ホホバロウ等のオイル、ワックス類;流動パラフィン、スクワラン、プリスタン、オゾケライト、パラフィン、セレシン、ワセリン、マイクロクリスタリンワックス等の炭化水素類;オレイン酸、イソステアリン酸、ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、ベヘン酸、ウンデシレン酸等の高級脂肪酸類;セチルアルコール、ステアリルアルコール、イソステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、ミリスチルアルコール、セトステアリルアルコール等の高級アルコール等;イソオクタン酸セチル、ミリスチン酸イソプロピル、イソステアリン酸ヘキシルデシル、アジピン酸ジイソプロピル、セバチン酸ジ−2−エチルヘキシル、乳酸セチル、リンゴ酸ジイソステアリル、ジ−2−エチルヘキサン酸エチレングリコール、ジカプリン酸ネオペンチルグリコール、ジ−2−ヘプチルウンデカン酸グリセリン、トリ−2−エチルヘキサン酸グリセリン、トリ−2−エチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、テトラ−2−エチルヘキサン酸ペンタンエリトリット等の合成エステル油類;ジメチルポリシロキサン、メチルフェニルポリシロキサン、ジフェニルポリシロキサン等の鎖状ポリシロキサン;オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサンシロキサン等の環状ポリシロキサン;アミノ変性ポリシロキサン、ポリエーテル変性ポリシロキサン、アルキル変性ポリシロキサン、フッ素変性ポリシロキサン等の変性ポリシロキサン等のシリコーン油等の油剤類;脂肪酸セッケン(ラウリン酸ナトリウム、パルミチン酸ナトリウム等)、ラウリル硫酸カリウム、アルキル硫酸トリエタノールアミンエーテル等のアニオン界面活性剤類;塩化ステアリルトリメチルアンモニウム、塩化ベンザルコニウム、ラウリルアミンオキサイド等のカチオン界面活性剤類;イミダゾリン系両性界面活性剤(2−ココイル−2−イミダゾリニウムヒドロキサイド−1−カルボキシエチロキシ2ナトリウム塩等)、ベタイン系界面活性剤(アルキルベタイン、アミドベタイン、スルホベタイン等)、アシルメチルタウリン等の両性界面活性剤類;ソルビタン脂肪酸エステル類(ソルビタンモノステアレート、セスキオレイン酸ソルビタン等)、グリセリン脂肪酸類(モノステアリン酸グリセリン等)、プロピレングリコール脂肪酸エステル類(モノステアリン酸プロピレングリコール等)、硬化ヒマシ油誘導体、グリセリンアルキルエーテル、POEソルビタン脂肪酸エステル類(POEソルビタンモノオレエート、モノステアリン酸ポリオキエチレンソルビタン等)、POEソルビット脂肪酸エステル類(POE−ソルビットモノラウレート等)、POEグリセリン脂肪酸エステル類(POE−グリセリンモノイソステアレート等)、POE脂肪酸エステル類(ポリエチレングリコールモノオレート、POEジステアレート等)、POEアルキルエーテル類(POE2−オクチルドデシルエーテル等)、POEアルキルフェニルエーテル類(POEノニルフェニルエーテル等)、プルロニック型類、POE・POPアルキルエーテル類(POE・POP2−デシルテトラデシルエーテル等)、テトロニック類、POEヒマシ油・硬化ヒマシ油誘導体(POEヒマシ油、POE硬化ヒマシ油等)、ショ糖脂肪酸エステル、アルキルグルコシド等の非イオン界面活性剤類;ビス(N−ラウロイルグルタミン酸)リジン等のアシル(ポリ)アミノ酸及び/又はその塩;ポリエチレングリコール、グリセリン、1,3−ブチレングリコール、エリスリトール、ソルビトール、キシリトール、マルチトール、プロピレングリコール、ジプロピレングリコール、ジグリセリン、イソプレングリコール、1,2−ペンタンジオール、2,4−ヘキサンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール等の多価アルコール類;ピロリドンカルボン酸ナトリウム、乳酸、乳酸ナトリウム等の保湿成分類;表面を処理されていても良い、マイカ、タルク、カオリン、合成雲母、炭酸カルシウム、炭酸マグネシウム、無水ケイ酸(シリカ)、酸化アルミニウム、硫酸バリウム等の粉体類、;表面を処理されていても良い、ベンガラ、黄酸化鉄、黒酸化鉄、酸化コバルト、群青、紺青、酸化チタン、酸化亜鉛の無機顔料類;表面を処理されていても良い、雲母チタン、魚燐箔、オキシ塩化ビスマス等のパール剤類;レーキ化されていても良い赤色202号、赤色228号、赤色226号、黄色4号、青色404号、黄色5号、赤色505号、赤色230号、赤色223号、橙色201号、赤色213号、黄色204号、黄色203号、青色1号、緑色201号、紫色201号、赤色204号等の有機色素類;ポリエチレン末、ポリメタクリル酸メチル、ナイロン粉末、オルガノポリシロキサンエラストマー等の有機粉体類;パラアミノ安息香酸系紫外線吸収剤;アントラニル酸系紫外線吸収剤;サリチル酸系紫外線吸収剤、;桂皮酸系紫外線吸収剤、;ベンゾフェノン系紫外線吸収剤;糖系紫外線吸収剤;2−(2’−ヒドロキシ−5’−t−オクチルフェニル)ベンゾトリアゾール、4−メトキシ−4’−t−ブチルジベンゾイルメタン等の紫外線吸収剤類;エタノール、イソプロパノール等の低級アルコール類;ビタミンA又はその誘導体、ビタミンB6塩酸塩、ビタミンB6トリパルミテート、ビタミンB6ジオクタノエート、ビタミンB2又はその誘導体、ビタミンB12、ビタミンB15又はその誘導体等のビタミンB類;α−トコフェロール、β−トコフェロール、γ−トコフェロール、ビタミンEアセテート等のビタミンE類、ビタミンD類、ビタミンH、パントテン酸、パンテチン、ピロロキノリンキノン等のビタミン類等;フェノキシエタノール等の抗菌剤などが好ましく例示できる。かかる成分と、前記の必須の成分とを常法に従って処理することにより、本発明の化粧料は製造できる。 In the cosmetic of the present invention, in addition to the above-mentioned components, components usually used in cosmetics can be optionally contained. Examples of such ingredients include macadamia nut oil, avocado oil, corn oil, olive oil, rapeseed oil, sesame oil, castor oil, safflower oil, cottonseed oil, jojoba oil, coconut oil, palm oil, liquid lanolin, hydrogenated coconut oil, Hardened oil, mole, hardened castor oil, beeswax, candelilla wax, carnauba wax, ibotarou, lanolin, reduced lanolin, hard lanolin, jojoba oil, waxes; liquid paraffin, squalane, pristane, ozokerite, paraffin, ceresin, petrolatum, Hydrocarbons such as microcrystalline wax; higher fatty acids such as oleic acid, isostearic acid, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, undecylenic acid; cetyl alcohol, stearyl alcohol, isostearyl alcohol Cole, higher alcohols such as behenyl alcohol, octyldodecanol, myristyl alcohol, cetostearyl alcohol, etc .; cetyl isooctanoate, isopropyl myristate, hexyldecyl isostearate, diisopropyl adipate, di-2-ethylhexyl sebacate, cetyl lactate, malic acid Diisostearyl, di-2-ethylhexanoic acid ethylene glycol, dicaprate neopentyl glycol, di-2-heptylundecanoic acid glycerin, tri-2-ethylhexanoic acid glycerin, tri-2-ethylhexanoic acid trimethylolpropane, tri Synthetic ester oils such as trimethylolpropane isostearate and pentane erythritol tetra-2-ethylhexanoate; dimethylpolysiloxane, methylphenylpolysiloxane Sun, chain polysiloxane such as diphenylpolysiloxane; cyclic polysiloxane such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexanesiloxane; amino-modified polysiloxane, polyether-modified polysiloxane, alkyl-modified polysiloxane, Oil agents such as silicone oils such as modified polysiloxanes such as fluorine-modified polysiloxanes; Anionic surfactants such as fatty acid soap (sodium laurate, sodium palmitate, etc.), potassium lauryl sulfate, triethanolamine ether of alkyl sulfates; Cationic surfactants such as stearyltrimethylammonium, benzalkonium chloride, laurylamine oxide; imidazoline-based amphoteric surfactants (2-cocoyl-2-imidazoli Amphoteric surfactants such as nium hydroxide-1-carboxyethyloxy disodium salt), betaine surfactants (alkyl betaine, amide betaine, sulfobetaine, etc.), acylmethyl taurine; sorbitan fatty acid esters (sorbitan mono) Stearates, sorbitan sesquioleate, etc.), glycerin fatty acids (glyceryl monostearate, etc.), propylene glycol fatty acid esters (propylene glycol monostearate, etc.), hardened castor oil derivatives, glycerin alkyl ethers, POE sorbitan fatty acid esters ( POE sorbitan monooleate, polyoxyethylene sorbitan monostearate, etc.), POE sorbite fatty acid esters (POE-sorbite monolaurate, etc.), POE glycerin fatty acid ester (POE-glycerin monoisostearate, etc.), POE fatty acid esters (polyethylene glycol monooleate, POE distearate, etc.), POE alkyl ethers (POE2-octyldodecyl ether, etc.), POE alkyl phenyl ethers (POE nonylphenyl ether) ), Pluronic types, POE / POP alkyl ethers (POE / POP2-decyltetradecyl ether, etc.), Tetronics, POE castor oil / hardened castor oil derivatives (POE castor oil, POE hardened castor oil, etc.), Sho Nonionic surfactants such as sugar fatty acid esters and alkyl glucosides; Acyl (poly) amino acids and / or salts thereof such as bis (N-lauroylglutamic acid) lysine; polyethylene glycol, glycerin, 1,3-butylene Recall, erythritol, sorbitol, xylitol, maltitol, propylene glycol, dipropylene glycol, diglycerin, isoprene glycol, 1,2-pentanediol, 2,4-hexanediol, 1,2-hexanediol, 1,2-octane Polyhydric alcohols such as diol; moisturizing ingredients such as sodium pyrrolidonecarboxylate, lactic acid, sodium lactate; surface-treated mica, talc, kaolin, synthetic mica, calcium carbonate, magnesium carbonate, silicic anhydride (Silica), powders such as aluminum oxide and barium sulfate; inorganic pigments such as bengara, yellow iron oxide, black iron oxide, cobalt oxide, ultramarine, bitumen, titanium oxide, zinc oxide, which may be treated on the surface Kind; Mica titanium, fish whose surface may be treated Pearl agents such as phosphorus foil and bismuth oxychloride; red 202, red 228, red 226, yellow 4, blue 404, yellow 5, red 505, red 230, which may be raked Organic dyes such as red 223, orange 201, red 213, yellow 204, yellow 203, blue 1, green 201, purple 201, red 204; polyethylene powder, polymethyl methacrylate, Organic powders such as nylon powder and organopolysiloxane elastomer; paraaminobenzoic acid UV absorbers; anthranilic acid UV absorbers; salicylic acid UV absorbers; cinnamic acid UV absorbers; benzophenone UV absorbers; Sugar-based ultraviolet absorbers; 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole, 4-methoxy-4′-t- UV absorbers such as butyldibenzoylmethane; lower alcohols such as ethanol and isopropanol; vitamin A or its derivatives, vitamin B6 hydrochloride, vitamin B6 tripalmitate, vitamin B6 dioctanoate, vitamin B2 or its derivatives, vitamin B12, Vitamin B such as vitamin B15 or a derivative thereof; vitamin E such as α-tocopherol, β-tocopherol, γ-tocopherol, vitamin E acetate, vitamin D, vitamin H, pantothenic acid, panthetin, pyrroloquinoline quinone Preferred examples include antibacterial agents such as phenoxyethanol. The cosmetic of the present invention can be produced by treating these components and the above essential components according to a conventional method.
以下に、実施例を挙げて、更に詳細に本発明について説明を加える。 Hereinafter, the present invention will be described in more detail with reference to examples.
以下に示す処方に従って、本発明の洗浄用の皮膚外用剤である、クレンジング化粧料を作成した。即ち、イ、ロの成分を80℃に加温し、イに徐々にロを加え粗ベシクルを作成し、これをエクストルーダーで処理し、ベシクル分散液1を得た。ベシクルであることは偏光顕微鏡により、脂質二重膜構造の存在から確認した。別途、ハ、ニをそれぞれ80℃に加温し、ハ、ニ、ホを80℃に温度調整した後、ハに攪拌下ニの成分を加えて乳化し、更にホを加え中和し、攪拌冷却を行った。温度が50℃になったところでへのベシクル分散液1を加え、30℃まで攪拌冷却し、クレンジング化粧料1を得た。ベシクル分散液のビス(N−ラウロイルグルタミル)リジンを水添レシチンに置換してリポソーム分散液1を作成し、同様に処理して、比較例1を作成した。 In accordance with the formulation shown below, a cleansing cosmetic, which is a skin external preparation for cleaning of the present invention, was prepared. That is, the components of (a) and (b) were heated to 80 ° C., and (b) was gradually added to prepare a crude vesicle, which was treated with an extruder to obtain a vesicle dispersion 1. The vesicle was confirmed by the presence of a lipid bilayer structure by a polarizing microscope. Separately, heat C and D to 80 ° C, adjust the temperature of C, D and H to 80 ° C, add emulsified ingredients to C under stirring, neutralize by adding H and stir. Cooling was performed. When the temperature reached 50 ° C., vesicle dispersion 1 was added, and the mixture was stirred and cooled to 30 ° C. to obtain cleansing cosmetic 1. Liposome dispersion 1 was prepared by substituting hydrogenated lecithin for bis (N-lauroylglutamyl) lysine in the vesicle dispersion, and Comparative Example 1 was prepared in the same manner.
<試験例1>
ベシクル分散液1を水で100倍希釈し、標準液とし、クレンジング化粧料1、比較例1を40℃で1ヶ月保存し、リボフラビンをマーカーとして、顕微鏡下、標準液を対照としてベシクルの計数を行い、検体のベシクルの観察個数/標準液のベシクルの観察個数×100で表されるベシクル維持率(%)を求めた。結果を表2に示す。斯くの如くに、リポソームはクレンジングのような溶剤成分の多い製剤系では、二重膜構造が崩壊し、個数が減じるのに対し、本願発明のベシクルは個数が安定に維持されていることがわかる。
<Test Example 1>
The vesicle dispersion 1 was diluted 100 times with water, used as a standard solution, and the cleansing cosmetic 1 and comparative example 1 were stored at 40 ° C. for 1 month, and the vesicles were counted under the microscope and the standard solution as a control using riboflavin as a marker. The vesicle maintenance rate (%) expressed by the number of specimen vesicles observed / the number of standard vesicles observed × 100 was determined. The results are shown in Table 2. Thus, it can be seen that in the formulation system with many solvent components such as cleansing, the liposome has a double membrane structure collapsed and the number decreases, whereas the number of vesicles of the present invention is maintained stably. .
以下に示す処方に従って、本発明の洗浄用の皮膚外用剤である、クレンジング化粧料を作成した。即ち、イ、ロの成分を80℃に加温し、イに徐々にロを加え粗ベシクルを作成し、これをエクストルーダーで処理し、ベシクル分散液2を得た。ベシクルであることは偏光顕微鏡により、脂質二重膜構造の存在から確認した。別途、ハ、ニをそれぞれ80℃に加温し、ハ、ニ、ホを80℃に温度調整した後、ハに攪拌下ニの成分を加えて乳化し、更にホを加え中和し、攪拌冷却を行った。温度が50℃になったところでへのベシクル分散液2を加え、30℃まで攪拌冷却し、クレンジング化粧料2を得た。このものの、実施例1の手法で求めた、ベシクル維持率は97%
であった。
In accordance with the formulation shown below, a cleansing cosmetic, which is a skin external preparation for cleaning of the present invention, was prepared. That is, the components (a) and (b) were heated to 80 ° C., and (b) was gradually added to prepare a crude vesicle, which was treated with an extruder to obtain a vesicle dispersion 2. The vesicle was confirmed by the presence of a lipid bilayer structure by a polarizing microscope. Separately, heat C and D to 80 ° C, adjust the temperature of C, D and H to 80 ° C, add emulsified ingredients to C under stirring, neutralize by adding H and stir. Cooling was performed. When the temperature reached 50 ° C., vesicle dispersion 2 was added, and the mixture was stirred and cooled to 30 ° C. to obtain cleansing cosmetic 2. However, the vesicle maintenance rate obtained by the method of Example 1 was 97%.
Met.
以下に示す処方に従って、本発明の洗浄用の皮膚外用剤である、クレンジング化粧料を作成した。即ち、イ、ロの成分を80℃に加温し、イに徐々にロを加え粗ベシクルを作成し、これをエクストルーダーで処理し、ベシクル分散液3を得た。ベシクルであることは偏光顕微鏡により、脂質二重膜構造の存在から確認した。別途、ハ、ニをそれぞれ80℃に加温し、ハ、ニ、ホを80℃に温度調整した後、ハに攪拌下ニの成分を加えて乳化し、更にホを加え中和し、攪拌冷却を行った。温度が50℃になったところでへのベシクル分散液3を加え、30℃まで攪拌冷却し、クレンジング化粧料3を得た。このものの、実施例1の手法で求めた、ベシクル維持率は98%であった。 In accordance with the formulation shown below, a cleansing cosmetic, which is a skin external preparation for cleaning of the present invention, was prepared. That is, the components of a and b were heated to 80 ° C., and b was gradually added to i to prepare a crude vesicle, which was treated with an extruder to obtain a vesicle dispersion 3. The vesicle was confirmed by the presence of a lipid bilayer structure by a polarizing microscope. Separately, heat C and D to 80 ° C, adjust the temperature of C, D and H to 80 ° C, add emulsified ingredients to C under stirring, neutralize by adding H and stir. Cooling was performed. When the temperature reached 50 ° C., vesicle dispersion 3 was added, and the mixture was stirred and cooled to 30 ° C. to obtain cleansing cosmetic 3. However, the vesicle maintenance rate determined by the method of Example 1 was 98%.
以下に示す処方に従って、本発明の化粧料である、水性洗浄化粧料を作成した。即ち、イ、ロの成分を80℃に加温し、イに徐々にロを加え粗ベシクルを作成し、これをエクストルーダーで処理し、ベシクル分散液1を得た。ベシクルであることは偏光顕微鏡により、脂質二重膜構造の存在から確認した。別途、ハ、ニをそれぞれ80℃に加温し、ハを真空乳化釜に仕込み、80℃に温度調整した後、攪拌下ニの成分を加えて中和し、真空で攪拌冷却を行った。温度が50℃になったところでホのベシクル分散液1を加え、30℃まで攪拌冷却し、水性洗浄化粧料5を得た。ベシクル分散液のビス(N−ラウロイルグルタミル)リジンを水添レシチンに置換してリポソーム分散液1を作成し、同様に処理して、比較例2を作成した。このものを試験例1の要領で評価した。結果を表6に示す。これより、本発明のベシクルは安定性に優れることがわかる。 In accordance with the formulation shown below, an aqueous cleansing cosmetic that is a cosmetic of the present invention was prepared. That is, the components of (a) and (b) were heated to 80 ° C., and (b) was gradually added to prepare a crude vesicle, which was treated with an extruder to obtain a vesicle dispersion 1. The vesicle was confirmed by the presence of a lipid bilayer structure by a polarizing microscope. Separately, C and D were each heated to 80 ° C., and C was charged into a vacuum emulsification kettle, adjusted to 80 ° C., neutralized by adding the components of D under stirring, and cooled with stirring under vacuum. When the temperature reached 50 ° C., vesicle dispersion 1 was added, and the mixture was stirred and cooled to 30 ° C. to obtain an aqueous cleaning cosmetic 5. Liposome dispersion 1 was prepared by substituting hydrogenated lecithin for bis (N-lauroylglutamyl) lysine in the vesicle dispersion, and Comparative Example 2 was prepared in the same manner. This was evaluated in the same manner as in Test Example 1. The results are shown in Table 6. This shows that the vesicle of the present invention is excellent in stability.
本発明は、クレンジング化粧料等の化粧料に応用できる。 The present invention can be applied to cosmetics such as cleansing cosmetics.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008108256A JP2009256253A (en) | 2008-04-17 | 2008-04-17 | Microsphere for cosmetic and cosmetic containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008108256A JP2009256253A (en) | 2008-04-17 | 2008-04-17 | Microsphere for cosmetic and cosmetic containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009256253A true JP2009256253A (en) | 2009-11-05 |
JP2009256253A5 JP2009256253A5 (en) | 2011-05-26 |
Family
ID=41384157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008108256A Pending JP2009256253A (en) | 2008-04-17 | 2008-04-17 | Microsphere for cosmetic and cosmetic containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2009256253A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012157628A1 (en) * | 2011-05-18 | 2012-11-22 | 株式会社ダイセル | Oil composition for cosmetic material |
JP2013001698A (en) * | 2011-06-21 | 2013-01-07 | Fancl Corp | Oily gel cleansing composition |
JP2013231023A (en) * | 2012-04-06 | 2013-11-14 | Kanagawa Univ | Cosmetic and method for producing cosmetic |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1043578A (en) * | 1996-07-30 | 1998-02-17 | Lion Corp | Production of endoplasmic reticulum dispersion liquid |
JP2002068954A (en) * | 2000-08-25 | 2002-03-08 | Shiseido Co Ltd | Composition for external use for moisture retention |
JP2006008536A (en) * | 2004-06-23 | 2006-01-12 | Noevir Co Ltd | External preparation for skin |
JP2006225403A (en) * | 2005-06-17 | 2006-08-31 | Asahi Kasei Chemicals Corp | Oily gel cleansing cream |
JP2006225368A (en) * | 2005-06-17 | 2006-08-31 | Asahi Kasei Chemicals Corp | Gel composition and method for preparing the same |
JP2006290894A (en) * | 2006-05-10 | 2006-10-26 | Asahi Kasei Chemicals Corp | Liposome and liposome preparation |
JP2007186498A (en) * | 2006-12-01 | 2007-07-26 | Asahi Kasei Chemicals Corp | Oily gel-like composition |
JP2007332088A (en) * | 2006-06-16 | 2007-12-27 | Pola Chem Ind Inc | External preparation for skin suitable for vesicle system |
JP2008019230A (en) * | 2006-06-16 | 2008-01-31 | Pola Chem Ind Inc | Ceramide-containing external preparation for skin |
JP2008255109A (en) * | 2007-03-13 | 2008-10-23 | Kose Corp | Vesicle composition and external preparation for skin blended with vesicle composition |
-
2008
- 2008-04-17 JP JP2008108256A patent/JP2009256253A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1043578A (en) * | 1996-07-30 | 1998-02-17 | Lion Corp | Production of endoplasmic reticulum dispersion liquid |
JP2002068954A (en) * | 2000-08-25 | 2002-03-08 | Shiseido Co Ltd | Composition for external use for moisture retention |
JP2006008536A (en) * | 2004-06-23 | 2006-01-12 | Noevir Co Ltd | External preparation for skin |
JP2006225403A (en) * | 2005-06-17 | 2006-08-31 | Asahi Kasei Chemicals Corp | Oily gel cleansing cream |
JP2006225368A (en) * | 2005-06-17 | 2006-08-31 | Asahi Kasei Chemicals Corp | Gel composition and method for preparing the same |
JP2006290894A (en) * | 2006-05-10 | 2006-10-26 | Asahi Kasei Chemicals Corp | Liposome and liposome preparation |
JP2007332088A (en) * | 2006-06-16 | 2007-12-27 | Pola Chem Ind Inc | External preparation for skin suitable for vesicle system |
JP2008019230A (en) * | 2006-06-16 | 2008-01-31 | Pola Chem Ind Inc | Ceramide-containing external preparation for skin |
JP2007186498A (en) * | 2006-12-01 | 2007-07-26 | Asahi Kasei Chemicals Corp | Oily gel-like composition |
JP2008255109A (en) * | 2007-03-13 | 2008-10-23 | Kose Corp | Vesicle composition and external preparation for skin blended with vesicle composition |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012157628A1 (en) * | 2011-05-18 | 2012-11-22 | 株式会社ダイセル | Oil composition for cosmetic material |
JPWO2012157628A1 (en) * | 2011-05-18 | 2014-07-31 | 株式会社ダイセル | Cosmetic oil composition |
JP2013001698A (en) * | 2011-06-21 | 2013-01-07 | Fancl Corp | Oily gel cleansing composition |
JP2013231023A (en) * | 2012-04-06 | 2013-11-14 | Kanagawa Univ | Cosmetic and method for producing cosmetic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2007332088A5 (en) | ||
JP2008019230A5 (en) | ||
JP2009084232A (en) | Emulsion formulation-type powder-containing external preparation for skin | |
JP5827079B2 (en) | Powder-containing skin external preparation | |
JP2008297238A (en) | Water-in-oil emulsion type powder-containing external preparation for skin | |
JP2007230929A (en) | Face wash for removing horny plug | |
JP2009256253A (en) | Microsphere for cosmetic and cosmetic containing the same | |
JP2007277191A (en) | Cosmetic of oil-in-water type emulsion dosage form | |
JP2009040738A (en) | Water-in-oil emulsifier type external preparation for skin | |
JP2007308384A (en) | Emulsion type external preparation for skin | |
JP4563194B2 (en) | Composition for external use | |
JP2009256254A (en) | Microsphere for cosmetic and cosmetic containing the microsphere | |
JP2007308379A (en) | Emulsion type external preparation for skin | |
JP5368005B2 (en) | Skin external preparation with cleansing function | |
JP2007254308A (en) | Oil-in-water type external preparation for skin | |
JP2007254308A5 (en) | ||
JP2009256253A5 (en) | ||
JP2008120756A (en) | Emulsified skin external preparation containing powder | |
JP5068091B2 (en) | Emulsifier type skin external preparation | |
JP2007308386A (en) | Water-in-oil emulsion type external preparation for skin | |
JP2009256254A5 (en) | ||
JP2007254346A (en) | Skin care preparation of water-in-oil type emulsion emulsion dosage form | |
JP4960004B2 (en) | Ubidecalenone-containing cosmetic in vesicle dispersion dosage form | |
JP2004182641A (en) | Cosmetic with suppressed stigging | |
JP6640556B2 (en) | Oil-in-water liquid bath agent and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110412 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110412 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20110412 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120717 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120731 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121001 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130226 |